Miquel y Costas & Miquel (MCM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 May, 2026Executive summary
Net sales reached €168.5 million in H1 2025, up 2.6% year-over-year, driven by growth in tobacco and industrial products.
EBITDA decreased by 7.8% to €40.6 million, and net profit fell 9.2% to €24.4 million compared to H1 2024.
The period was marked by high uncertainty, inflationary pressures on energy, and adverse currency movements, especially USD devaluation.
Continued execution of the 2024–2026 investment plan, with significant capital deployed in fixed assets and sustainability initiatives.
Financial highlights
Operating income dropped 10.2% to €30.6 million; pre-tax profit declined 9.4% to €32.1 million year-over-year.
Cash flow after tax was €34.4 million, down 6.5% from H1 2024.
Net financial position (net cash) stood at €62.3 million at June 2025, down from €75.4 million at December 2024.
Dividend payments totaled €4.5 million, with a nominal DPA of €0.113 per share.
Outlook and guidance
Expects full-year 2025 results to be in line with 2024, targeting around €48.7 million net profit.
Ongoing investment program focused on technology, logistics, and sustainability improvements.
Latest events from Miquel y Costas & Miquel
- EBITDA and net income grew despite lower sales, with positive outlook sustained.MCM
Q3 202412 May 2026 - Sales up 10.1% year-over-year, but net profit dipped 1.5% amid higher energy costs.MCM
Q1 202512 May 2026 - Slight revenue growth offset by lower profit as costs and FX pressures weighed on results.MCM
Q3 202512 May 2026 - Net profit up 10.5% to €26.8M, with margin recovery and ongoing investment amid global risks.MCM
Q2 202412 May 2026 - Net profit up 14% to €48.7M, with stable sales and strong investment amid global uncertainties.MCM
Q4 202412 May 2026 - Revenue rose 1.5% but profits fell amid cost pressures and currency headwinds in 2025.MCM
Q4 202512 May 2026 - Sales and profits declined year-over-year, but sequential growth and investment support resilience.MCM
Q1 202612 May 2026